ST
Sulaiman Thottiparambil Hasainar
About Sulaiman Thottiparambil Hasainar
Data last updated:
Sulaiman Thottiparambil Hasainar is a Director at Conlex Life Science Private Limited (since 2022). The company operates in Trading. Conlex Life Science Private Limited reported revenue of ₹82 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Conlex Life Science Private Limited U51909KL2021PTC068219 | Director | 02 May 2022 | 2021 | ₹82 Lakh (FY 2025) | Active |
Board colleagues of Sulaiman Thottiparambil Hasainar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Conrad Alwyn | 09119132 | Conlex Life Science Private Limited | Director |
| Dhibu Paul | 09119131 | Conlex Life Science Private Limited | Managing Director |
| Satheesar Kappooril Sajith | 09592234 | Conlex Life Science Private Limited | Director |
| Shihabudheen Kizhakkepalachuvadu Sainudheen | 09592195 | Conlex Life Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sulaiman Thottiparambil Hasainar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sulaiman Thottiparambil Hasainar
Sulaiman Thottiparambil Hasainar currently holds 1 directorship: Conlex Life Science Private Limited (Director, since 02 May 2022, revenue ₹82 Lakh (FY 2025)).
Sulaiman Thottiparambil Hasainar was first appointed on 02 May 2022 as Director at Conlex Life Science Private Limited.
The current boards of Sulaiman Thottiparambil Hasainar's companies include Conrad Alwyn (Conlex Life Science Private Limited), Dhibu Paul (Conlex Life Science Private Limited), Satheesar Kappooril Sajith (Conlex Life Science Private Limited), Shihabudheen Kizhakkepalachuvadu Sainudheen (Conlex Life Science Private Limited).